| Three months of rifapentine and isoniazid for latent tuberculosis infection TR Sterling, ME Villarino, AS Borisov, N Shang, F Gordin, ... New England Journal of Medicine 365 (23), 2155-2166, 2011 | 1115 | 2011 |
| Four-month rifapentine regimens with or without moxifloxacin for tuberculosis SE Dorman, P Nahid, EV Kurbatova, PPJ Phillips, K Bryant, KE Dooley, ... New England Journal of Medicine 384 (18), 1705-1718, 2021 | 352 | 2021 |
| Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis M Weiner, D Benator, W Burman, CA Peloquin, A Khan, A Vernon, ... Clinical infectious diseases 40 (10), 1481-1491, 2005 | 267 | 2005 |
| Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine M Weiner, W Burman, A Vernon, D Benator, CA Peloquin, A Khan, S Weis, ... American journal of respiratory and critical care medicine 167 (10), 1341-1347, 2003 | 265 | 2003 |
| Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid ME Villarino, NA Scott, SE Weis, M Weiner, MB Conde, B Jones, ... JAMA pediatrics 169 (3), 247-255, 2015 | 231 | 2015 |
| Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis W Burman, D Benator, A Vernon, A Khan, B Jones, C Silva, C Lahart, ... American journal of respiratory and critical care medicine 173 (3), 350-356, 2006 | 208 | 2006 |
| Mannan antigenemia in the diagnosis of invasive Candida infections. MH Weiner, WJ Yount The Journal of clinical investigation 58 (5), 1045-1053, 1976 | 200 | 1976 |
| Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations M Weiner, C Peloquin, W Burman, CC Luo, M Engle, TJ Prihoda, ... Antimicrobial agents and chemotherapy 54 (10), 4192-4200, 2010 | 166 | 2010 |
| Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis W Burman, S Weis, A Vernon, A Khan, D Benator, B Jones, C Silva, ... The international journal of tuberculosis and lung disease 11 (12), 1282-1289, 2007 | 157 | 2007 |
| Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial R Belknap, D Holland, PJ Feng, JP Millet, JA Caylà, NA Martinson, ... Annals of internal medicine 167 (10), 689-697, 2017 | 148 | 2017 |
| Immunodiagnosis of systemic candidiasis: mannan antigenemia detected by radioimmunoassay in experimental and human infections MH Weiner, M Coats-Stephen Journal of Infectious Diseases 140 (6), 989-993, 1979 | 148 | 1979 |
| Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium SE Dorman, S Goldberg, JE Stout, G Muzanyi, JL Johnson, M Weiner, ... The Journal of infectious diseases 206 (7), 1030-1040, 2012 | 138 | 2012 |
| Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial SE Dorman, RM Savic, S Goldberg, JE Stout, N Schluger, G Muzanyi, ... American journal of respiratory and critical care medicine 191 (3), 333-343, 2015 | 127 | 2015 |
| Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors TR Sterling, Z Zhao, A Khan, RE Chaisson, N Schluger, B Mangura, ... The International Journal of Tuberculosis and Lung Disease 10 (5), 542-549, 2006 | 122 | 2006 |
| Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment MA De Groote, P Nahid, L Jarlsberg, JL Johnson, M Weiner, G Muzanyi, ... PloS one 8 (4), e61002, 2013 | 121 | 2013 |
| Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin M Weiner, W Burman, CC Luo, CA Peloquin, M Engle, S Goldberg, ... Antimicrobial agents and chemotherapy 51 (8), 2861-2866, 2007 | 121 | 2007 |
| Antigen detection in the diagnosis of invasive aspergillosis: utility in controlled, blinded trials MH WEINER, GH TALBOT, SL GERSON, G FILICE, PA CASSILETH Annals of internal medicine 99 (6), 777-782, 1983 | 121 | 1983 |
| Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergillomas CP Andrews, MH Weiner The American journal of medicine 73 (3), 372-380, 1982 | 115 | 1982 |
| Biomarkers of tuberculosis severity and treatment effect: a directed screen of 70 host markers in a randomized clinical trial GB Sigal, MR Segal, A Mathew, L Jarlsberg, M Wang, S Barbero, N Small, ... EBioMedicine 25, 112-121, 2017 | 114 | 2017 |
| Antigenemia detected by radioimmunoassay in systemic aspergillosis MH WEINER Annals of internal medicine 92 (6), 793-796, 1980 | 114 | 1980 |
